放射治療設備的印度市場評估:各產品，各用途，各終端用戶，各地區，機會，預測(2018年度～2032年度)

印度放射治療設備市場規模預計將從 2024 財年的 4.1222 億美元增至 2032 財年的 7.0827 億美元，並預計從 2025 財年到 2032 財年將以 7.00% 的複合年增長率增長。由於癌症負擔的增加、本地製造、技術進步和公私合作夥伴關係，該市場正在不斷增長。

由於新癌症患者數量的增加、醫療支出的增加以及政府加強癌症治療的努力，市場正在擴大。蓬勃發展的經濟和快速增長的中產階級人口促使了對先進醫療技術採用的巨額投資。此外，透過強大的當地能力實現醫療器材生產自給自足的動機是減少對進口的依賴。強而有力的公私夥伴關係促進了先進治療中心的建立。此外，癌症篩檢和早期發現意識的提高也促使對放射治療服務的需求增加。該國渴望成為全球醫療中心，因此需要部署先進的放射治療設備，這對於提供優質的癌症治療和在國際市場上具有競爭力至關重要。

此外，專業癌症中心和放射治療設施等醫療中心的擴張將增加放射治療設備的可用性和可近性。例如，2024 年 4 月，新德里哈丁夫人醫學院開始使用近距離放射治療設備治療第一位癌症患者。這種治療是為患有某些癌症和其他疾病的患者提供的。更多設施的建立將改善放射治療服務的可近性，從而增加對患者進一步治療的放射治療設備的需求。

本報告提供印度的放射治療設備市場相關調查分析，提供市場規模與預測，市場動態，主要企業的形勢等資訊。

目錄

第1章 計劃的範圍和定義

第2章 調查手法

第3章 摘要整理

第4章 印度的放射治療設備市場預測(2018年度～2032年度)

• 市場規模的分析與預測
  • 金額
  • 數量
• 市場佔有率的分析與預測
  • 各產品
  • 各用途
  • 各終端用戶
  • 各地區
  • 市場佔有率分析:各企業(金額)(前五名公司和其他 - 2024年度)
• 市場地圖分析(2024年度)
  • 各產品
  • 各用途
  • 各終端用戶
  • 各地區

第5章 供需分析

第6章 進口和出口的分析

第7章 價值鏈分析

第8章 波特的五力分析

第9章 大環境分析

第10章 價格分析

第11章 市場動態

• 推動市場要素
• 市場課題

第12章 市場趨勢與發展

第13章 法規結構和革新

• 法規當局的認證

第14章 專利形勢

第15章 案例研究

第16章 競爭情形

• 市場前五名領導者企業的競爭矩陣
• 前五名公司的SWOT分析
• 主要企業前五名公司的形勢
  • Elekta Medical Systems India Pvt. Ltd.
  • Accuray Medical Equipment India Pvt. Ltd.
  • Koninklijke Philips N.V.
  • Ion Beam Applications S.A.
  • Vision RT Ltd.
  • BEBIG Medical GmbH
  • Mitsubishi Electric India Pvt. Ltd.
  • Varian Medical Systems, Inc.
  • Society for Applied Microwave Electronics Engineering & Research
  • Brainlab India Pvt. Ltd.

第17章 策略性推薦

第18章 本公司相關資料，免責聲明

India radiotherapy devices market is projected to grow at a CAGR of 7.00% from FY2025 to FY2032, increasing from USD 412.22 million in FY2024 to USD 708.27 million by FY2032. The market for radiotherapy devices in India is growing due to an increase in the cancer burden, indigenous manufacturing, technological advancements, and public-private partnerships.

The Indian radiotherapy devices market is expanding as new cancer cases are growing, healthcare expenditure is rising, and the government is taking initiatives to enhance cancer care. The booming economy and rapidly growing middle-class population in the nation have resulted in huge investments in adopting advanced healthcare technologies. Moreover, the motivation for the achievement of self-sufficiency in the production of medical equipment with strong indigenous capabilities is to reduce the dependence on imports. Strong public-private partnerships are making it easy to establish advanced treatment centers. Also, the increasing awareness of screening and early cancer detection further results in rising demand for radiotherapy services. The country's aspirations to position itself as a global healthcare hub create the need to equip the country with advanced radiotherapy equipment, which would prove indispensable in supplying quality cancer care and placing the country competitively in the international market.

Furthermore, the expansion of healthcare centers, such as specialized centers of cancer and radiation therapy facilities, enhances the availability and accessibility of radiotherapy equipment. For instance, in April 2024, Lady Hardinge Medical College, located in New Delhi, inaugurated and treated its first cancer patient with brachytherapy equipment. This treatment is provided for patients suffering from some kinds of cancers and other diseases. With more facilities being set up, this will increase accessibility to radiotherapy services, hence increasing the demand for radiotherapy devices in further treatment of patients.

Increasing Cancer Burden Influencing India Radiotherapy Devices Market Growth

The rising burden of cancer cases in India is resulting in a higher demand for radiotherapy devices, which, in turn, leads to the expansion of the radiotherapy devices market. The alarming increase in cancer cases in India, which gets worsened by significantly delayed diagnoses resulting in higher mortality rates along with lower recoveries, necessitates raising public awareness and educational awareness among professionals to address this significant issue. Predictive and precision medicine, and integrated AI diagnostics, provide further hope to tackle this issue. The demand for radiotherapy devices is expected to significantly increase as diagnostic methods become more common and affordable. Increasingly systematic screening programs focusing on prevalent cancers, as well as on high-risk individuals, are essential. Risk identification and improvement of data sharing constitute part of the government's digital health initiatives. Collaboration between the public and private sectors is of utmost importance in adequately dealing with the growing burden of cancer. Such interaction will promote demand for better-advanced radiotherapy technologies that improve patient care and outcomes. Public-Private Partnerships (PPPs) have significantly increased access to cancer care in India. For example, Varian Medical Systems, Inc. has partnered with the Central and State Governments to establish radiation therapy centers in public hospitals. The government provides the infrastructure, while private operators supply the equipment and services at agreed-upon prices for the benefit of patients.

Increasing Government Initiatives to Drive the Radiotherapy Devices Market Growth

The government has initiated various schemes and policies to encourage growth in the medical devices market, particularly radiotherapy equipment. The Make in India initiative supports the domestic manufacturing of medical devices, including those used in cancer treatment, to reduce import dependency. Moreover, in the Production Linked Incentive Scheme (PLI) scheme, incentives are proposed for specific cancer care technologies, including advanced radiotherapy technologies.

Such developments allow growth and innovation for the medical industry in India, which, in turn, attracts investments that help research institutions develop technology to increase the adoption of advanced medical devices in health facilities. In this case, with growing awareness about treatments for cancer treatment, more patients will look at the need for advanced therapies, increasing device demand and promoting the Indian radiotherapy devices market progression. For instance, in June 2024, Apollo Cancer Centres partnered with Accuray Medical Equipment India Pvt. Ltd., to introduce India's first Robotic Stereotactic Radiotherapy Program. It will provide advanced training for radiation oncologists, physicists, and technicians in Chennai and Bangalore locations. This program will feature hands-on training and in-depth discussions to enhance local medical education, providing improved cancer care using the Cyberknife system.

Developments in Technology to Propel India Radiotherapy Devices Market Growth

With the increase in cancer cases, there is an emerging demand for advanced technologies in treatment, especially among late-stage cancers that are challenging to treat. The rise in cancer cases in India highlights the market for an advanced and affordable healthcare system covering cancer care so that anyone can easily approach cancer care. Innovations in radiotherapy from key players in the healthcare sector are involved in improving comfort for cancer patients. Many hospitals and medical facilities have embraced these innovations. Advanced treatment techniques used include proton therapy, precision radiation therapies such as intensity-modulated radiation therapy, and image-guided radiation therapy. For instance, in August 2024, Sahyadri Hospitals Private Limited installed the TomoTherapy Radixact X9 system with VitalHold technology. This radiotherapy solution has unfolded new dimensions in treating cancer by providing precision, significantly when tumors are affected by patient movement. It is the first installation in Asia with the system and features Auto Beam Hold, which will cease radiation if the patient moves beyond safe limits. Advanced imaging capabilities significantly improve the detection and accuracy of treatment in tumors, hence elevating patient care.

Hospitals to Hold Substantial Market Share

Hospitals in India account for a relatively more significant share of the radiotherapy devices market due to the increasing patient requirements for cancer treatment, technological advancements, and government initiatives towards healthcare infrastructure development. Their capability to provide comprehensive care invests in modern equipment that enhances the quality of service delivered. This trend accelerates market growth, attracts further investments in innovations, and brings about healthy competition among the manufacturers, which results in better accessibility and affordability of radiotherapy services amongst patients located in various parts of the country. Therefore, hospitals are increasingly installing such advanced radiotherapy devices in their facility to improve patient outcomes. For instance, in April 2024, the Swami Rama Himalayan University (SRHU) Cancer Research Institute (Himalayan Hospital) installed the Halcyon B Linear Accelerator for radiotherapy at the Himalayan Hospital. With cancer cases on a leap and bound in India, this high-end machine will enhance the present treatment portfolio of the patients. Being the first private teaching hospital in Uttarakhand wielding this technology, Himalayan Hospital would ensure the pain of the side effects among its affected patients is not so grueling during treatment and, hence, bring a highly positive change.

Future Market Scenario (FY2025 -FY2032F)

Technologically advanced elements, such as precision radiation therapy, integration of AI for treatment planning, and new technologies like proton therapy, will drive the Indian market for radiotherapy devices. Major companies are stressing cost-effective solutions and are enhancing patient care through personalized treatment approaches. In September 2024, Accuray Medical Equipment India Pvt. Ltd (Accuray) unveiled its CE-marked Accuray Helix system in India. The CT-guided helical radiotherapy system will provide high performance and efficiency, reaching into emerging markets where advanced cancer care, including radiotherapy is often limited to urban areas with fewer facilities such as a linear accelerator.

Key Players Landscape and Outlook

Major players in India radiotherapy devices market are building their presence through partnerships with government hospitals, increasing the distribution outreach, and investing in local manufacturing. It includes improving access to best-in-class cancer treatment and resultant gains to strengthen their competitive position in the market.

In November 2023, Elekta AB (Elekta) received an order worth USD 40 million from Krishna Institute of Medical Sciences (KIMS) in Hyderabad. The order includes cutting-edge equipment like the Elekta Unity MR-Linacs and Leksell Gamma Knife systems, which will enable KIMS to deliver more personalized cancer treatments and enhance the care of their patients while minimizing side effects.

In July 2023, Elekta AB (Elekta) collaborated with GE HealthCare Technologies Inc., intending to scale up accessibility to precise radiation therapy in India. Through this agreement, these companies will ensure that complete systems for imaging and treatment are delivered to hospitals, providing radiation therapy to cancer patients and, hence, improving the care of patients.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. India Radiotherapy Devices Market Outlook, FY2018-FY2032F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
  • 4.1.2. By Volume
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Product
    • 4.2.1.1. External Beam Radiation Therapy Devices
      • 4.2.1.1.1. Advanced Linear Accelerators
        • 4.2.1.1.1.1. Gamma Knife
        • 4.2.1.1.1.2. Cyberknife
        • 4.2.1.1.1.3. TomoTherapy
        • 4.2.1.1.1.4. MRI LINAC
      • 4.2.1.1.2. Conventional Linear Accelerators
      • 4.2.1.1.3. Conventional Cobalt-60 Teletherapy Units
      • 4.2.1.1.4. Proton Therapy Devices
        • 4.2.1.1.4.1. Cyclotrons
        • 4.2.1.1.4.2. Synchrotron
        • 4.2.1.1.4.3. Synchrocyclotron
    • 4.2.1.2. Internal Beam Radiation Therapy Devices
      • 4.2.1.2.1. Brachytherapy Devices
      • 4.2.1.2.2. Consumables
    • 4.2.1.3. Others
  • 4.2.2. By Application
    • 4.2.2.1. Lung Cancer
    • 4.2.2.2. Breast Cancer
    • 4.2.2.3. Prostate Cancer
    • 4.2.2.4. Head and Neck Cancer
    • 4.2.2.5. Other Applications
  • 4.2.3. By End-user
    • 4.2.3.1. Hospitals
    • 4.2.3.2. Ambulatory Surgical Centers
    • 4.2.3.3. Cancer Care Centers
  • 4.2.4. By Region
    • 4.2.4.1. North
    • 4.2.4.2. South
    • 4.2.4.3. East
    • 4.2.4.4. West and Central
  • 4.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, FY2024)
• 4.3. Market Map Analysis, FY2024
  • 4.3.1. By Product
  • 4.3.2. By Application
  • 4.3.3. By End-user
  • 4.3.4. By Region

5. Demand Supply Analysis

6. Import and Export Analysis

7. Value Chain Analysis

8. Porter's Five Forces Analysis

9. PESTLE Analysis

10. Pricing Analysis

11. Market Dynamics

• 11.1. Market Drivers
• 11.2. Market Challenges

12. Market Trends and Developments

13. Regulatory Framework and Innovation

• 13.1. Regulatory Approvals

14. Patent Landscape

15. Case Studies

16. Competitive Landscape

• 16.1. Competition Matrix of Top 5 Market Leaders
• 16.2. SWOT Analysis for Top 5 Players
• 16.3. Key Players Landscape for Top 5 Market Players
  • 16.3.1. Elekta Medical Systems India Pvt. Ltd.
    • 16.3.1.1. Company Details
    • 16.3.1.2. Key Management Personnel
    • 16.3.1.3. Products and Services
    • 16.3.1.4. Financials (As Reported)
    • 16.3.1.5. Key Market Focus and Geographical Presence
    • 16.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
  • 16.3.2. Accuray Medical Equipment India Pvt. Ltd.
  • 16.3.3. Koninklijke Philips N.V.
  • 16.3.4. Ion Beam Applications S.A.
  • 16.3.5. Vision RT Ltd.
  • 16.3.6. BEBIG Medical GmbH
  • 16.3.7. Mitsubishi Electric India Pvt. Ltd.
  • 16.3.8. Varian Medical Systems, Inc.
  • 16.3.9. Society for Applied Microwave Electronics Engineering & Research
  • 16.3.10. Brainlab India Pvt. Ltd.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

17. Strategic Recommendations

18. About Us and Disclaimer

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. India Radiotherapy Devices Market, By Value, In USD Million, FY2018-FY2032F
• Figure 2. India Radiotherapy Devices Market, By Volume, In Million Units, FY2018-FY2032F
• Figure 3. India Radiotherapy Devices Market Share (%), By Product, FY2018-FY2032F
• Figure 4. India Radiotherapy Devices Market Share (%), By Application, FY2018-FY2032F
• Figure 5. India Radiotherapy Devices Market Share (%), By End-user, FY2018-FY2032F
• Figure 6. India Radiotherapy Devices Market Share (%), By Region, FY2018-FY2032F
• Figure 7. By Product Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 8. By Application Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 9. By End-user Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 10. By Region Map-Market Size (USD Million) & Growth Rate (%), FY2024